Anticorps Polyclonal de lapin anti-KMT2C
KMT2C Polyclonal Antibody for WB, IHC, Indirect ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
WB, IHC, Indirect ELISA
Conjugaison
Non conjugué
N° de cat : 28437-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
28437-1-PBS cible KMT2C dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | KMT2C Protéine recombinante Ag28875 |
| Nom complet | myeloid/lymphoid or mixed-lineage leukemia 3 |
| Masse moléculaire calculée | 541 kDa |
| Poids moléculaire observé | 541kDa, 269 kDa |
| Numéro d’acquisition GenBank | NM_170606 |
| Symbole du gène | KMT2C |
| Identification du gène (NCBI) | 58508 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
Lysine (K)-specific methyltransferase 2C (KMT2C, also known as MLL3) belongs to the mixed-lineage leukemia (MLL) family of histone methyltransferases which methylate the histone 3 tail at lysine 4 (H3K4) as part of the complex proteins associated with Set 1 (COMPASS) complex. Although originally identified as oncogenic fusions in leukemia, genome-wide mutation studies have revealed frequent, presumably loss-of-function, mutations in various members of the MLL family, including MLL2/KMT2B, MLL3/KMT2C, and MLL4/KMT2D in a variety of malignancies, particularly solid tumors. Mechanistic studies of KMT2C in normal cells have focused primarily on its role in enhancer regulation by deposition of H3K4me1 marks.





